In another study, this variant of ACTN4 protein was predominantly observed in high grade neuroendocrine lung tumors, including 60% of SCLC and 51% of large cell neuroendocrine carcinomas (LCNEC) [30]. The gene discussed is ACTN4; the disease is large cell neuroendocrine carcinoma.